Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.06
Delayed Data
As of 4:00pm ET
 -0.07 / -0.77%
Today’s Change
5.49
Today|||52-Week Range
9.60
+15.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line65.0K2.0M1.1M-2.5M
 
 
 
 
 
Depreciation3.8M4.4M5.6M7.1M
 
 
 
 
 
Total Other Cash Flow3.9M3.7M3.2M3.7M
 
 
 
 
 
Funds From Operations7.8M10.1M10.0M8.3M
 
 
 
 
 
Funds From/For Other Operating Expenses8.3M7.9M517.0K1.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-492.0K2.2M9.5M6.4M
 
 
 
 
 
 
InvestingCapital Expenditures-2.6M-2.0M-3.8M-2.2M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-5.8M-72.9M
 
 
 
Net Cash Flow Investing-3.7M-2.0M-9.6M-75.2M
 
 
 
 
 
 
FinancingShort Term Borrowings4.6M-4.2M-4.3M10.0M
 
 
 
 
 
Long Term Borrowings0.000.000.0051.7M
 
 
Long Term Debt Reduction-2.2M-2.6M-3.6M-4.1M
 
 
 
 
 
Net Proceeds Stock Sale511.0K9.5M36.9M935.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing500.0K0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.4M2.8M29.0M58.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-760.0K3.0M28.9M-10.3M